Results 271 to 280 of about 700,247 (353)

Experimental hyperkinetic pulmonary hypertension. Tolerance after biventricular hypertrophy produced by a femoral arteriovenous fistula.

, 1968
Charles H. Dart, Thomas Montgomery, Richard M. Peters   +2 more
openalex  

A Case of Primary Pulmonary Hypertension Associated with Thrombus of The Right Main Pulmonary Artery

, 1960
Magojiro Maekawa, Yutaka Ogata, S. Iguchi, Mikio Sakai, Chuichi Kawai, Etsu Hashida, Reizo Kusukawa, Tasuku Ota, Kikugo Masuda, Yukio Morita, Takao Mori, Tadao Tamura, Kuniki Hayashi, Yoichi Seriu, Keishiro Kawamura   +14 more
openalex   +2 more sources

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Tachycardia and persistent pulmonary hypertension of the newborn. [PDF]

Front Pediatr
Kaltsogianni O, Bhat R, Greenough A, Dassios T.   +3 more
europepmc   +1 more source

Effects of Intravenous Lanatoside C on the Pulmonary Circulation in Patients with Pulmonary Hypertension

, 1963
Tetsuya Watanabe, Ryo Katori, M Murai, Tan Watanabe, Junshi Oda   +4 more
openalex   +2 more sources

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Corrigendum to “Exercise ventilatory reserve predicts survival in adult congenital heart disease associated pulmonary arterial hypertension with Eisenmenger physiology” [Int J Cardiol Congenit Heart Dis, Volume 7, March 2022, 100331]

International Journal of Cardiology Congenital Heart Disease
Chinthaka B. Samaranayake, Ruth McNiven, Aleksander Kempny, Carl Harries, Laura C. Price, Michael Gatzoulis, Konstantinos Dimopoulos, Stephen J. Wort, Colm McCabe   +8 more
doaj   +1 more source

Chronic Pulmonary Hypertension in Pulmonary Diseases

, 1961
Kazuhiko Katayama
openalex   +2 more sources